U.S. Organ Transplant Pharmaceuticals Markets

U.S. Organ Transplant Pharmaceuticals Markets

 

RELEASE DATE
09-Aug-2002
REGION
North America
Research Code: A213-01-00-00-00
SKU: HC00837-NA-MR_04540
AvailableYesPDF Download
$3,950.00
In stock
SKU
HC00837-NA-MR_04540
$3,950.00
DownloadLink
ENQUIRE NOW

Description

This report discusses in depth an emerging medical field dealing with the treatment of organ and tissue diseases through the replacement of defective organs with healthier, donated ones. The field of organ transplantation continues to evolve, as improved immunosuppression therapies emerge onto the market. These medicines increase the success of transplant survivals, and enable improved quality of life and contained healthcare costs. As research progresses, it is imperative for market participants to keep abreast of the leading issues and emerging therapies for organ transplant rejections. This report aims to provide participating companies with a tool to make market-intelligent decisions.

Table of Contents

Overview

  • The Immune System and Organ Transplant Rejection
  • The History of Organ Transplant Immunosuppression
  • The Nature of the Market
  • Report Scope and Segmentation

Market Dynamics

  • Challenges
  • Drivers
  • Restraints
  • Market Engineering Analysis

Forecasts and Trends

  • Market and Technology Trends
  • Revenue Forecasts
  • Market Share Analysis

Strategic Recommendations

  • Strategic Recommendation 1
  • Strategic Recommendation 2
  • Strategic Recommendation 3

Market Engineering Awards

  • Product Line Strategy - Novartis Pharmaceutical Corporation
  • Technology Innovation - Isotechnika Inc.
  • Market Penetration - Roche Laboratories
  • Product Innovation - SangStat Medical Corporation
  • Competitive Strategy Award- Abbott Laboratories

Total Demand and Supply Analysis

Demand and Supply Analysis by Organ Type

Overview

Forecasts and Trends

Competitive Analysis

Emerging Technologies

Organ Transplants

Healthcare Infrastructure

Demographics

Related Research
This report discusses in depth an emerging medical field dealing with the treatment of organ and tissue diseases through the replacement of defective organs with healthier, donated ones. The field of organ transplantation continues to evolve, as improved immunosuppression therapies emerge onto the market. These medicines increase the success of transplant survivals, and enable improved quality of life and contained healthcare costs. As research progresses, it is imperative for market participants to keep abreast of the leading issues and emerging therapies for organ transplant rejections. This report aims to provide participating companies with a tool to make market-intelligent decisions.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A213-01-00-00-00
Is Prebook No